• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Neuropathy (1983); Pain (1994); Urinary Frequency (2275); Ambulation Difficulties (2544)
Event Type  Injury  
Event Description
It was reported that the patient underwent a transforaminal and posterolateral fusion surgery at l4-l5 using rhbmp-2/acs placed into the l4-5 interspace and facet joint.Post-op, the patient developed increasing low back pain and radiculopathy into his lower extremities.Severe pain and symptoms compelled the patient to undergo revision surgery.The patient continued to experience low back pain and left leg radiculopathy.He had difficulty in sitting, standing and walking for prolonged periods, and experienced urinary frequency.
 
Manufacturer Narrative
(b)(4): neither the device nor applicable imaging study films or patient medical records were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted/used during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the patient was presented with the following pre-op diagnosis: 1.Status post motor vehicle accident with re-herniation l4-5.2.Severe extrusion l4-5, left with severe l5 nerve root compression and left-sided foot drop.3.Significant kyphosis on standing films at l4-l5.4.Morbid obesity preoperatively.5, previous history of laminectomy l4-5, left.He underwent following procedures: 1.Revision decompression l4-5, left with total facetectomy and lysis of adhesions.2.Transforaminal lumbar interbody fusion l4-5 through left facetectomy approach.3.Insertion of intervertebral biomechanical device l4-l5.4.Posterolateral fusion l4-ls (right facet technique).5.Non-segmental pedicle screw instrumentation l4-5 with minimally invasive technique).6.Harvest of local autograft bone from total facetectomy.7.Aspiration of right iliac crest bone marrow.As per operative notes, ¿a combination of rhbmp-2/acs, of vitoss and the local bone were then packed into the l4-5 interspace to create an interbody fusion.When this had been completed trial sizers were placed in the disk space and the best-fitting sizer was 11 mm.An 11mm peek intervertebral biomechanical device was packed with locally harvested autograft bone tamped into position and appropriately rotated.This was in excellent position in ap and lateral images.At this point, the wilson frame was let down to increase lordosis and the graft was pushed somewhat further.It was in excellent position." the patient was presented with the following post-op diagnosis: 1.Status post motor vehicle accident with re-herniation l4-5.2.Severe extrusion l4-5, left with severe l5 nerve root compression and left-sided foot drop.3.Significant kyphosis on standing films at l4-l5.4.Morbid obesity preoperatively.5.Previous history of laminectomy l4-5, left.6.Morbid obesity made decompression and fusion more challenging than usual.7.Severe epidural scarring l4-5 left made decompression and fusion much more challenging than usual requiring extensive lysis of adhesions and causing significant difficulty with visualization.No intra-op complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
huzefa mamoola
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key4485041
MDR Text Key5567503
Report Number1030489-2015-00233
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Reporter Occupation Attorney
Type of Report Initial,Followup
Report Date 04/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/02/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-